Tumor Response to Neoadjuvant Chemotherapy Correlates with the Expression of P-Glycoprotein and PCNA but Not GST-π in the Tumor Cells of Cervical Carcinoma
- 1 September 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 70 (3) , 365-371
- https://doi.org/10.1006/gyno.1998.5077
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB–IIB Invasive Cervical CancerGynecologic Oncology, 1996
- Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer--Where Does It Stand?Obstetrical & Gynecological Survey, 1996
- Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic managementInternational Journal of Gynecologic Cancer, 1996
- Markers of Chemoresistance in Ovarian Carcinomas: An Immunohistochemical Study of 86 CasesInternational Journal of Gynecological Pathology, 1996
- Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product p-glycoprotein in primary liver carcinomaCancer, 1994
- The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a reviewInternational Journal of Gynecologic Cancer, 1993
- Immunohistochemical Detection of P-Glycoprotein in Normal and Malignant Tissues: A Comparative Study of Three Monoclonal Antibodies, JSB-1, C 219 and 265/F4, against Different Epitopes Using Frozen and Paraffin Tissue SectionsTumor Biology, 1993
- Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy and survivalGynecologic Oncology, 1992
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989